Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 158,528 shares at $8.35 ($1.3M) on 2025-03-12, disclosed to the SEC on 2025-03-13.
Scheduled sale ($1.3M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.35 | 79,264 | $662K | 50.0% |
| 2 | $8.35 | 79,264 | $662K | 50.0% |
| Total | $8.35 avg | 158,528 | $1.3M | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2024-11-26 | $1.2M | — | Filing → |